MMI vs SRPT · rev $374.4M vs rev $1.13B
Marcus & Millichap Inc (MMI) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Marcus & Millichap Inc (MMI) is a real estate services company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported MMI revenue for 2026-06-30 was $374.4M. Net income was $809.0K. MMI currently screens at market cap $1.10B.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
MMI currently screens at market cap $1.10B. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the MMI and SRPT stock pages for the full models.
Not investment advice.